Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,334 across all filing types
Latest filing 2020-06-11 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
EMTN Programme Routine Technical Update
Regulatory Filings Classification · 98% confidence The document is very short (2373 characters) and explicitly states it is an announcement regarding the 'Publication of Prospectus' for an EMTN Programme, noting that the document has been approved by the FCA and is available via a URL. This fits the 'MENU VS MEAL' rule, indicating it is an announcement about a filing rather than the comprehensive report itself. The presence of 'RNS Number' and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) strongly suggests this is a general regulatory announcement. Since it is an announcement of a specific financial document (a Prospectus), and it is not a standard 10-K, IR, or ER, the most appropriate classification is Report Publication Announcement (RPA) because it announces the publication of a specific document, or RNS as a general regulatory filing. Given the explicit mention of 'Publication of Prospectus' and the structure typical of an RNS announcement detailing where to find the actual document, RPA is slightly more specific than the general RNS fallback, but RNS is also highly applicable. Since the document is an RNS announcement detailing the publication of a prospectus, and RPA is defined as 'Announcement regarding the timing, release, or publication of company reports', RPA is the best fit. If RPA were not available, RNS would be the fallback.
2020-06-11 English
EMTN Programme Routine Technical Update: Publication of a Prospectus
Capital/Financing Update Classification · 98% confidence The document is titled 'US$10,000,000,000 Euro Medium Term Note Programme' and explicitly states it is a 'Base Prospectus' issued in compliance with the Prospectus Regulation, approved by the UK Financial Conduct Authority (FCA). It details the terms and conditions for issuing Notes (debt securities) under a Programme, including risk factors, dealer information, and admission to listing on the London Stock Exchange. This structure—a comprehensive document outlining the terms for issuing securities over a period—is characteristic of a Prospectus, which is a key component of capital raising and financing activities. While it is a prospectus, the closest fit among the provided codes for a document detailing financing activities and security issuance terms is 'Capital/Financing Update' (CAP), as it is the foundational document for debt issuance, rather than a standard periodic report (10-K, IR) or a simple announcement (RPA, RNS). Given the context of establishing a Note Programme, CAP is the most appropriate classification.
2020-06-11 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2020-06-01 English
BLOCK LISTING INTERIM REVIEW
Foreign Filer Report
2020-06-01 English
Block listing Interim Review
Regulatory Filings Classification · 98% confidence The document is a 'Block Listing Six Monthly Return' filed by AstraZeneca PLC via the London Stock Exchange's RNS (Regulatory News Service). This filing details the issuance of shares under various employee share option plans over a six-month period. Since it specifically reports on the issuance of shares related to capital schemes and changes in the balance of unallotted securities, it falls under the category of share issues and capital changes.
2020-06-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number : 5615O' header and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange. The content details the total number of voting rights and issued share capital as of a specific date (31 May 2020), which is a mandatory disclosure under the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of regulatory announcement, which is not a full financial report (like 10-K or IR) but a specific regulatory update, fits best under the general 'Regulatory Filings' category (RNS) or potentially 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Since it is a notification about the denominator for voting rights calculations rather than the results of a vote, RNS is the most appropriate general regulatory filing code, especially given the explicit RNS branding.
2020-06-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.